title: Haem precursor delta-aminolaevulinic acid induces activation of the cytosolic iron regulatory protein 1.
abstract: Control of cellular iron homoeostasis is performed by iron regulatory protein 1 (IRP1) through post-transcriptional modifications. This protein is sensitive to intracellular iron availability, being activated at low iron levels and inactivated at high iron levels, conditions that signal the increased expression of the transferrin receptor or of ferritin respectively. IRP1 is known to be activated by some oxidants such as H2O2 and NO. delta-Aminolaevulinic acid (ALA), previously found to produce reactive oxygen species and a carbon-centred radical, to release iron from ferritin, and to increase rat liver and brain non-haem iron and ferritin, was investigated for its effects on IRP1 activity in cultured hamster pulmonary fibroblasts. We have found that 1-2 mM ALA produced a 2-3-fold activation of IRP. On incubation with 1-4 mM succinylacetone methyl ester, a potent ALA dehydratase inhibitor, a 3-4-fold activation of the protein was observed, accompanied by a 40% increase in the intracellular ALA concentration. When cells were incubated in the presence of ALA or succinylacetone methyl ester, N-acetylcysteine inhibited IRP1 activation, suggesting that the observed effect is mediated by an oxidative process. We surmise that ALA-induced IRP1 activation might act as a co-sensor of iron homoeostasis.
authors.affiliation: Instituto de Qu approximately ímica, Universidade de São Paulo, CP 26077, 05599-970 São Paulo, SP, Brasil.
authors.forename: H
authors.initials: H
authors.lastname: Carvalho
authors.forename: E J
authors.initials: EJ
authors.lastname: Bechara
authors.forename: R
authors.initials: R
authors.lastname: Meneghini
authors.forename: M
authors.initials: M
authors.lastname: Demasi
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000622:Aminolevulinic Acid / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D004591:Electrophoresis, Polyacrylamide Gel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005293:Ferritins / Q000235:genetics; D006418:Heme / Q000378:metabolism; D006706:Homeostasis / Q000502:physiology; D007501:Iron / Q000494:pharmacology; D035941:Iron Regulatory Protein 1; D035925:Iron-Regulatory Proteins; D007506:Iron-Sulfur Proteins / Q000378:metabolism*; D008168:Lung; D010084:Oxidation-Reduction; D000623:Porphobilinogen Synthase / Q000037:antagonists & inhibitors; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D035925:Iron-Regulatory Proteins; D007506:Iron-Sulfur Proteins; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D017382:Reactive Oxygen Species; D006418:Heme; D000622:Aminolevulinic Acid; D005293:Ferritins; D007501:Iron; D000623:Porphobilinogen Synthase; D035941:Iron Regulatory Protein 1; D000111:Acetylcysteine